drugset / Trial / NCT00888238

A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

NCT00888238

Phase 1 Completed 12 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindDiagnostic

Summary

This study will evaluate the effect of a single dose of sitagliptin on glucose dependent insulin secretion using a meal tolerance test (MTT) during a hyperglycemic clamp (HCG) procedure.

Timeline

Start
2009-05-12
Primary completion
2009-06-10
Completion
2009-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg Oral